Literature DB >> 17805487

6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) is up-regulated in high-grade astrocytomas.

Renate Kessler1, Franziska Bleichert, Jan-Peter Warnke, Klaus Eschrich.   

Abstract

The bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFK-2/FBPase-2) controls the glycolytic flux via the allosteric activator fructose 2,6-bisphosphate. Because of its proto-oncogenic character, the PFK-2/FBPase-2 of the PFKFB3 gene is assumed to play a critical role in tumorigenesis. We investigated the PFKFB3 expression in 40 human astrocytic gliomas and 20 non-neoplastic brain tissue specimens. The PFKFB3 protein levels were markedly elevated in high-grade astrocytomas relative to low-grade astrocytomas and corresponding non-neoplastic brain tissue, whereas no significant increase of PFKFB3 mRNA was observed in high-grade astrocytomas when compared with control tissue. In the group of glioblastomas the PFKFB3 protein inversely correlates with EGFR expression. The findings demonstrate that PFKFB3 up-regulation is a hallmark of high-grade astrocytomas offering an explanation for high glycolytic flux and lactate production in these tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17805487     DOI: 10.1007/s11060-007-9471-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  37 in total

Review 1.  Malignant glioma: genetics and biology of a grave matter.

Authors:  E A Maher; F B Furnari; R M Bachoo; D H Rowitch; D N Louis; W K Cavenee; R A DePinho
Journal:  Genes Dev       Date:  2001-06-01       Impact factor: 11.361

2.  Characterization of a human placental fructose-6-phosphate, 2-kinase/fructose-2,6-bisphosphatase.

Authors:  R Sakakibara; M Kato; N Okamura; T Nakagawa; Y Komada; N Tominaga; M Shimojo; M Fukasawa
Journal:  J Biochem       Date:  1997-07       Impact factor: 3.387

3.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

4.  Antiapoptotic function of RNA-binding protein HuR effected through prothymosin alpha.

Authors:  Ashish Lal; Tomoko Kawai; Xiaoling Yang; Krystyna Mazan-Mamczarz; Myriam Gorospe
Journal:  EMBO J       Date:  2005-04-28       Impact factor: 11.598

5.  Identification of PRG1, a novel progestin-responsive gene with sequence homology to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.

Authors:  J A Hamilton; M J Callaghan; R L Sutherland; C K Watts
Journal:  Mol Endocrinol       Date:  1997-04

6.  Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure.

Authors:  S Oudard; E Boitier; L Miccoli; S Rousset; B Dutrillaux; M F Poupon
Journal:  Anticancer Res       Date:  1997 May-Jun       Impact factor: 2.480

7.  PFKFB3 gene silencing decreases glycolysis, induces cell-cycle delay and inhibits anchorage-independent growth in HeLa cells.

Authors:  M N Calvo; R Bartrons; E Castaño; J C Perales; A Navarro-Sabaté; A Manzano
Journal:  FEBS Lett       Date:  2006-05-08       Impact factor: 4.124

8.  PIK3CA alterations in primary (de novo) and secondary glioblastomas.

Authors:  Daisuke Kita; Yasuhiro Yonekawa; Michael Weller; Hiroko Ohgaki
Journal:  Acta Neuropathol       Date:  2007-01-18       Impact factor: 17.088

Review 9.  Genetic pathways to primary and secondary glioblastoma.

Authors:  Hiroko Ohgaki; Paul Kleihues
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

10.  Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy.

Authors:  F A Howe; S J Barton; S A Cudlip; M Stubbs; D E Saunders; M Murphy; P Wilkins; K S Opstad; V L Doyle; M A McLean; B A Bell; J R Griffiths
Journal:  Magn Reson Med       Date:  2003-02       Impact factor: 4.668

View more
  23 in total

Review 1.  Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?

Authors:  Nissim Hay
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

2.  Role of sp transcription factors in the regulation of cancer cell metabolism.

Authors:  Michael C Archer
Journal:  Genes Cancer       Date:  2011-07

3.  PI3K-Akt signaling controls PFKFB3 expression during human T-lymphocyte activation.

Authors:  Helga Simon-Molas; Claudia Arnedo-Pac; Pere Fontova; Anna Vidal-Alabró; Esther Castaño; Ana Rodríguez-García; Àurea Navarro-Sabaté; Núria Lloberas; Anna Manzano; Ramon Bartrons
Journal:  Mol Cell Biochem       Date:  2018-02-12       Impact factor: 3.396

4.  MAPK14/p38α-dependent modulation of glucose metabolism affects ROS levels and autophagy during starvation.

Authors:  Enrico Desideri; Rolando Vegliante; Simone Cardaci; Ridvan Nepravishta; Maurizio Paci; Maria Rosa Ciriolo
Journal:  Autophagy       Date:  2014-07-10       Impact factor: 16.016

Review 5.  The p160/steroid receptor coactivator family: potent arbiters of uterine physiology and dysfunction.

Authors:  Maria M Szwarc; Ramakrishna Kommagani; Bruce A Lessey; John P Lydon
Journal:  Biol Reprod       Date:  2014-10-08       Impact factor: 4.285

Review 6.  Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells.

Authors:  Oleksandr H Minchenko; Katsuya Tsuchihara; Dmytro O Minchenko; Andreas Bikfalvi; Hiroyasu Esumi
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 7.  Stress eating and tuning out: cancer cells re-wire metabolism to counter stress.

Authors:  Zachary E Stine; Chi V Dang
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-10-07       Impact factor: 8.250

8.  Moderate grade hyperammonemia activates lactate dehydrogenase-4 and 6-phosphofructo-2-kinase to support increased lactate turnover in the brain slices.

Authors:  Aditi Mehrotra; Surendra Kumar Trigun
Journal:  Mol Cell Biochem       Date:  2013-05-24       Impact factor: 3.396

9.  Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review.

Authors:  Paolo E Porporato; Suveera Dhup; Rajesh K Dadhich; Tamara Copetti; Pierre Sonveaux
Journal:  Front Pharmacol       Date:  2011-08-25       Impact factor: 5.810

10.  The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activity.

Authors:  M M Reddy; M S Fernandes; A Deshpande; E Weisberg; H V Inguilizian; O Abdel-Wahab; A L Kung; R L Levine; J D Griffin; M Sattler
Journal:  Leukemia       Date:  2011-08-23       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.